Research of the Correlation Between Metabolic Syndrome, Retinal Thickness and Visual Acuity

Purpose: To investigate the relationship between retinal thickness (RT) and metabolic risks (MRs) in patients without retinal lesion.

Methods: Fifty-two patients over 60 y/o were divided into four groups according to their MRs of hypertension, hyperlipidemia or hyperglyceremia. After complete ophthalmic examination, optical coherence tomography was performed to measure RT.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Visual Acuity

Age range

65 year and older

Sex eligibility

All sexes

Study type

Observational

Primary location

Taipei Medical University - WanFang Hospital

Taipei, Taiwan

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

We enrolled the patients included age more than 60 years old, no positive finding during dilated fundus examination.

Exclusion criteria

The exclusion criteria were as followed:

systemic disease that will affect visual acuity evaluation (for example: CVA), *opaque cornea and vitreous
glaucoma
uvietis and other clinically established ocular disease.
According to the LOCS III11, those who had nuclear opalescence, nuclear color more than grade 3 or any grade of cortical cataract and posterior subcapsular cataract were also eliminated.

Sponsors and collaborators

Lead sponsor

Taipei Medical University WanFang Hospital

Other

Registry information

Important dates

Study start: 2009
Study completion: 2009
First posted: Oct 13, 2010
Registry last updated: Dec 21, 2010

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.

Completed